版本:
中国

BRIEF-Atyr Pharma reports issuance of U.S. patent that extends patent protection of physiocrines

March 15 Atyr Pharma Inc:

* Atyr Pharma announces issuance of U.S. patent that extends patent protection of physiocrines derived from 20 out of 20 human TRNA synthetases Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐